Sponsor or institution
Clinical trials and research at Ceric Sàrl
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Ceric Sàrl that are recruiting, at sites in 14 countries (most in Estonia (2), Italy (2), France (2)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 14Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Coronary Laser Atherectomy Registry in an International Network | — | Madrid | Recruiting | Jan 16, 2026 |
| Drug-coated balloon with bail-out bioresorbable scaffold versus scaffold alone for new coronary artery blockages | — | Tallinn | Recruiting | Jun 26, 2025 |
| Coronary thrombus removal with INDIGO CAT RX for anterior heart attacks. | — | Milan, Milani | Recruiting | Mar 20, 2025 |
| Surgical versus transcatheter aortic valve replacement for patients aged 65–75 | — | Graz and 48 other locations | Recruiting | Mar 6, 2025 |
| Evaluation of a new stent graft system for treating aortic arch and descending thoracic aorta conditions | — | Brest and 3 other locations | Recruiting | Jul 29, 2022 |
All recruiting trials (5)
-
Coronary Laser Atherectomy Registry in an International Network
This registry tests how well Excimer Laser Coronary Atherectomy (ELCA) works in real-world PCI for people with stable or acute coronary conditions across multiple countries.
-
Drug-coated balloon with bail-out bioresorbable scaffold versus scaffold alone for new coronary artery blockages
This test sees if using a drug-coated balloon with bail-out bioresorbable scaffold works as well as using a bioresorbable scaffold alone for adults 18–68 getting PCI for new coronary artery blockages, including certain heart attacks and unstable angina.
-
Coronary thrombus removal with INDIGO CAT RX for anterior heart attacks.
This trial will test whether using the INDIGO CAT RX device to suction clot during primary PCI reduces microvascular damage and heart muscle scarring in people with an anterior STEMI.
-
Surgical versus transcatheter aortic valve replacement for patients aged 65–75
This trial will test whether the Myval transcatheter heart valve works as well as surgical bioprosthetic aortic valve replacement for people aged 65 to 75 with symptomatic severe aortic stenosis.
-
Evaluation of a new stent graft system for treating aortic arch and descending thoracic aorta conditions
This study is testing a new stent graft system to see if it can safely help people with problems in their aortic arch and descending thoracic aorta, like aneurysms and dissections.
Quick answers
How many clinical trials run by Ceric Sàrl are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in Estonia (2 trials), Italy (2 trials), France (2 trials), Spain (2 trials), Austria (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.